Tsumura

Tsumura's history begins in 1893, when Tsumura Jushin founded a pharmaceutical business in Japan. The enterprise developed during a period when Japanese medicine was incorporating Western pharmaceutical methods while retaining and reorganizing older medical traditions. Tsumura's long-term specialization emerged from this interaction: traditional prescriptions were not treated only as household remedies, but increasingly as products that could be manufactured, packaged, quality-controlled, and distributed through a modern pharmaceutical business. During the first half of the twentieth century, the company built the foundations of its industrial identity. Its corporate history is associated with the Tsumura Junten-do name, and the business eventually adopted the Tsumura & Co. name used by the modern public company. The transition from individually prepared traditional medicines to standardized extract products was a major operational change. Instead of relying on a finished herbal mixture prepared at the point of sale, the manufacturer could produce reproducible extracts in controlled facilities and offer them in convenient dosage forms. The postwar development of Japan's healthcare and national health-insurance systems created the setting in which Kampo could become part of mainstream clinical practice. Tsumura expanded its range of prescription Kampo extract products and developed relationships with physicians, hospitals, pharmacies, and academic researchers. The company's products became identifiable components of Japanese pharmaceutical practice, with physicians prescribing particular formulas according to traditional diagnostic concepts and modern clinical needs. A defining feature of Tsumura's business is the management of medicinal plants as pharmaceutical raw materials. The company has had to develop expertise in botanical identification, cultivation, harvesting, processing, storage, extraction, and testing. Because Kampo formulas commonly contain several plant-derived ingredients, consistency in species, growing conditions, harvest timing, and preparation is important to the quality of the final medicine. Tsumura therefore developed supply-chain and production activities in Japan and China, including cultivation and raw-material processing associated with its Kampo manufacturing system. The company also increased research activity around the pharmacology and clinical application of Kampo. This work has included studies of traditional formulas in areas such as gastrointestinal symptoms, women's health, frailty, appetite, sleep, behavioral symptoms, pain, and supportive treatment. The research strategy has generally been to explain or validate established formulations within contemporary medical and pharmaceutical frameworks rather than to abandon their traditional identity. As the Kampo market matured, Tsumura became the most prominent dedicated Kampo pharmaceutical company in Japan. Its portfolio includes a large number of prescription formulas as well as over-the-counter products. The company's role extends beyond branding: it participates in raw-material procurement, botanical research, manufacturing, quality assurance, regulatory work, medical-information provision, and education concerning appropriate Kampo use. In the twenty-first century, Tsumura has continued to emphasize sustainable raw-material procurement, production capacity, scientific evidence, and the expansion of Kampo's role in healthcare. China has remained important both as a source and production location for medicinal plants and as a market and research environment. International expansion has been more limited than the company's domestic Japanese franchise, because Kampo prescribing, reimbursement, and regulatory recognition are particularly developed in Japan. Today, Tsumura remains an active publicly listed Japanese pharmaceutical company. Its historical significance lies in making Kampo a scalable, standardized, and institutionally accepted pharmaceutical business. Its continuing challenge is to preserve the knowledge and supply of traditional botanical formulas while meeting modern expectations for clinical evidence, safety, traceability, environmental stewardship, and manufacturing quality.

1. 2000Kampo research expanded

   The company continued to broaden scientific and clinical research supporting the use and quality of Kampo medicines.

   Source
2. 1983Tsumura & Co. name adopted

   The company changed its corporate name to Tsumura & Co., the name associated with its contemporary public-company identity.

   Source
3. 1936Corporate organization established

   The company adopted a modern corporate structure associated with the Tsumura Junten-do business.

   Source
4. 1893Business founded

   Tsumura Jushin established the pharmaceutical business that became the foundation of Tsumura's modern Kampo enterprise.

   Source

A specialist pharmaceutical company that integrates traditional Japanese Kampo prescriptions with standardized botanical sourcing, pharmaceutical manufacturing, clinical research, and physician-led healthcare.

• Prescription Kampo extract medicinesPrescription pharmaceuticals

  Tsumura's core product line consists of standardized powdered extracts made from traditional Kampo formulas. The products are prescribed by Japanese physicians and supplied through the medical system in numbered formula presentations. They cover a broad range of clinical uses, including gastrointestinal disorders, pain, women's health, respiratory symptoms, fluid-balance complaints, frailty, sleep, and supportive care. Their identity depends on both the traditional formula and the company's control of botanical sourcing, extraction, testing, and pharmaceutical production.

• ShakuyakukanzotoKampo prescription medicine

  A Kampo extract formula traditionally associated with muscle cramps and painful spasms, including certain acute cramping complaints. It is one of the best-known formulas in Tsumura's prescription portfolio and is used in Japanese clinical practice under physician direction. The product illustrates Tsumura's model of converting a classical multi-herb prescription into a standardized pharmaceutical extract.

• RikkunshitoKampo prescription medicine

  A traditional Kampo formula used in Japan for upper-gastrointestinal symptoms, appetite-related complaints, and conditions involving impaired digestive function. Tsumura has supported research into its clinical applications and mechanisms, making it an important example of the company's strategy of combining traditional indications with contemporary clinical investigation.

• YokukansanKampo prescription medicine

  A Kampo formula used in Japanese medicine in connection with irritability, sleep-related issues, and behavioral or neuropsychiatric symptoms in selected patients. It has attracted research attention beyond traditional indications and demonstrates how Tsumura's products are studied for potential roles in modern hospital and geriatric care.

• GoreisanKampo prescription medicine

  A traditional multi-herb Kampo formula associated with fluid-balance symptoms and selected headache, nausea, or edema-related complaints. As with other Tsumura products, its commercial form is a controlled extract rather than an individually compounded traditional preparation.

• Over-the-counter Kampo medicinesConsumer healthcare

  Tsumura also offers non-prescription Kampo products for consumer use. These products extend the company's traditional-medicine expertise beyond the prescription channel, while remaining subject to Japanese pharmaceutical labeling and regulatory requirements. The OTC range is distinct from the company's central prescription business in distribution and consumer positioning.

1. Tsumura corporate history
2. Tsumura company profile
3. Tsumura pharmaceutical business
4. Tsumura research and development
5. Tsumura integrated reports and investor information